Navigation Links
Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
Date:12/7/2007

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, December 7 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that Dr. Dalia Cohen, EVP, Global Head of R&D at Rosetta Genomics, will present at RBC Capital Markets 2007 Healthcare conference on Thursday, December 13, at 9:00 am EST at the Westin Hotel in New York.

A live audio webcast of the presentation will be available on the "Investors" section of the company's website, http://www.RosettaGenomics.com. A replay of the presentation will be available for 30 days after the conference.

About Rosetta Genomics

Rosetta Genomics (NASDAQ: ROSG) is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and other indications. For more information please visit: http://www.rosettagenomics.com

Contact: Media

Alan Zachary

T: +1(312)-944-6784

media@rosettagenomics.com

Investors

Juliane Snowden

T: +1(212)-213-0006

investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
2. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
3. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
4. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
5. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
6. NeoGenomics Announces Results for the 3rd Quarter 2007
7. Webcast Alert: Kaiser Permanente Residency Program Open House
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
10. BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
11. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: